These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 15138207)
1. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Charlton A; Blair V; Shaw D; Parry S; Guilford P; Martin IG Gut; 2004 Jun; 53(6):814-20. PubMed ID: 15138207 [TBL] [Abstract][Full Text] [Related]
2. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
3. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Shaw D; Blair V; Framp A; Harawira P; McLeod M; Guilford P; Parry S; Charlton A; Martin I Gut; 2005 Apr; 54(4):461-8. PubMed ID: 15753528 [TBL] [Abstract][Full Text] [Related]
4. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383 [TBL] [Abstract][Full Text] [Related]
5. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer. Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759 [TBL] [Abstract][Full Text] [Related]
6. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658 [TBL] [Abstract][Full Text] [Related]
11. Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma. Lee HE; Smyrk TC; Zhang L Hum Pathol; 2018 Apr; 74():64-72. PubMed ID: 29307626 [TBL] [Abstract][Full Text] [Related]
12. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094 [TBL] [Abstract][Full Text] [Related]
13. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763 [TBL] [Abstract][Full Text] [Related]
14. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family. Oliveira C; Moreira H; Seruca R; de Oliveira MC; Carneiro F Virchows Arch; 2005 Feb; 446(2):181-4. PubMed ID: 15735979 [TBL] [Abstract][Full Text] [Related]
15. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748 [TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer. Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785 [TBL] [Abstract][Full Text] [Related]
17. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938 [TBL] [Abstract][Full Text] [Related]
19. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Rocha JP; Gullo I; Wen X; Devezas V; Baptista M; Oliveira C; Carneiro F Histopathology; 2018 Dec; 73(6):878-886. PubMed ID: 30014492 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria. van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]